MJNA - Medical Marijuana, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.0200
-0.0007 (-3.38%)
At close: 3:58PM EST
Stock chart is not supported by your current browser
Previous Close0.0207
Open0.0205
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0194 - 0.0205
52 Week Range0.0194 - 0.0800
Volume5,418,618
Avg. Volume6,330,296
Market Cap221.846M
Beta (5Y Monthly)-0.74
PE Ratio (TTM)N/A
EPS (TTM)-0.0090
Earnings DateNov 21, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • PR Newswire

    Medical Marijuana, Inc. Appoints Squar Milner LLP as New Independent Auditor

    Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), announced today that it has appointed Squar Milner LLP ("Squar Milner") as the Company's new independent registered public accounting firm. Squar Milner will begin work immediately on the audit of Medical Marijuana, Inc.'s December 31, 2019 consolidated balance sheet.

  • PR Newswire

    Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Announces Completion of NIH-NIDA Phase 1 Grant and Results from Temple University

    Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its portfolio investment company Kannalife, Inc. ("Kannalife") (OTC: KLFE), a biopharmaceutical company specializing in the research and development of cannabinoid therapeutics, has completed its phase 1 study funded by a grant (1R41DA044898-01) from the National Institutes of Health's (NIH) National Institute on Drug Abuse (NIDA).

  • PR Newswire

    Medical Marijuana, Inc. Flagship CBD Oil RSHO-X™ Clinical Study Results Show Promise

    Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that a clinical study conducted in Mexico using its Real Scientific Hemp Oil-X™ cannabidiol (CBD) oil has been completed and published in the EC Neurology (ECNE), an internationally peer-reviewed journal that publishes articles related to worldwide research in neuroscience.

  • Medical Marijuana, Inc. Subsidiary Kannaway® Welcomes Renowned Wellness Expert and Certified Nutrition Coach Daniel Miller as Company Spokesperson
    PR Newswire

    Medical Marijuana, Inc. Subsidiary Kannaway® Welcomes Renowned Wellness Expert and Certified Nutrition Coach Daniel Miller as Company Spokesperson

    Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that renowned wellness expert and Certified Nutrition Coach Daniel Miller has joined its subsidiary Kannaway®. Miller, in partnership with Kannaway® as their new spokesperson, has created the world's first cannabis fitness program and is developing a new fitness-based product line to support that program.

  • PR Newswire

    Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Announces New Chief Medical Officer

    Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary HempMeds® Brasil has appointed Dr. Rubens Wajnsztejn as the Company's Chief Medical Officer.

  • PR Newswire

    Medical Marijuana, Inc. Subsidiary Kannaway® Expands Into Russia, Kazakhstan and Kyrgyzstan

    Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® is now available in Russia, Kazakhstan and Kyrgyzstan.

  • PR Newswire

    Medical Marijuana, Inc. Subsidiary HempMeds® Flagship Product Real Scientific Hemp Oil™ Featured in Us Weekly

    Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary HempMeds®' flagship cannabidiol (CBD) product Real Scientific Hemp Oil™ (RSHO™) was featured in popular lifestyle outlet Us Weekly.

  • PR Newswire

    Medical Marijuana, Inc. Subsidiary Kannaway Named Most Popular CBD MLM in 2020

    Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® has been named the Most Popular Cannabidiol (CBD) MLM Company in HealthMJ's new 2020 list. Additionally, Kannaway® has been listed among the Top 100 MLM Companies of 2020 by Business for Home.

  • PR Newswire

    Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Opens Mexico City Office

    Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today the opening of its subsidiary HempMeds® Mexico's new office in Mexico City.

  • PR Newswire

    Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies to Acquire Leading Oncology Research and Development Company Sapphire Biotech, Inc.

    Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its investment company AXIM® Biotechnologies, Inc. (OTCQB: AXIM) ("AXIM® Biotech" or "AXIM") has signed a binding term sheet to acquire leading oncology research and development company Sapphire Biotech, Inc. ("Sapphire") as a wholly-owned subsidiary.

  • PR Newswire

    Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Secures New INCI Name for Its Prospective Anti-Inflammatory and Antioxidant Ingredient Atopidine™

    Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its portfolio investment company Kannalife, Inc. ("Kannalife") (OTC: KLFE), a biopharmaceutical company specializing in the research and development of cannabinoid therapeutics, received a designated International Nomenclature Cosmetic Ingredient (INCI) name for its patent-pending molecule and flagship consumer product to be sold under the trademark Atopidine™.

  • PR Newswire

    HempMeds®, Subsidiary of Medical Marijuana, Inc., Becomes One of the First Companies to Join Recently Launched Leafly Market

    Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary HempMeds® has become one of the first 21 companies to be listed on the Leafly Market, an online store with the largest selection of hemp-derived cannabidiol (CBD) products independently tested for cannabinoid potency, pesticides and heavy metals.

  • Medical Marijuana, Inc. Appoints New Chief Financial Officer
    PR Newswire

    Medical Marijuana, Inc. Appoints New Chief Financial Officer

    Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that it has promoted its VP of Corporate Finance Brooke Beers to Chief Financial Officer of the Company.

  • PR Newswire

    Medical Marijuana, Inc. Subsidiary Kannaway® Showcases International Industry Leadership at European Parliament

    Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® will be speaking in the European Parliament at a special event on "The State of Hemp in Europe," to be held on Thursday, December 12, 2019, in Brussels, Belgium.

  • Benzinga

    Medical Marijuana Inc. Portfolio Company Kannalife Now Trading On The OTCQB

    Research recently published in the Journal of Molecular Neuroscience showed that KLS-13019 was 200 times more potent, 10 times more bioavailable, 5 times safer and 1000 times more effective than CBD.

  • PR Newswire

    Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Commences Trading on OTCQB Under Ticker Symbol "KLFE"

    Medical Marijuana, Inc. (the "Company") (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its portfolio investment company Kannalife, Inc. ("Kannalife") (OTC: KLFE), a biopharmaceutical company specializing in the research and development of cannabinoid therapeutics, officially commenced trading on the OTC Markets under the ticker symbol "KLFE." Medical Marijuana, Inc. became Kannalife's original investor in 2013 and currently owns approximately 26.17% common equity in the company.

  • PR Newswire

    Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Applauds ANVISA's New Regulations of Medical Cannabis Products in Brazil

    Medical Marijuana, Inc. ("the Company") (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that subsidiary HempMeds® Brasil applauds ANVISA (the National Agency for Health Supervision) for unanimously approving the regulation of medical marijuana to be sold at pharmacies and drugstores nationwide. Brazil's new regulations will be published soon on the Federal Official Gazette and entered into law 90 days after that.

  • PR Newswire

    Medical Marijuana, Inc. Subsidiary Kannaway® Receives Two 2019 Best in Biz Awards

    Medical Marijuana, Inc. ("the Company") (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® received a Bronze Best in Biz Award for Most Innovative Product of the Year – Consumer for its high-quality hemp-derived cannabidiol (CBD) products. Also, Kannaway® CEO Blake Schroeder received a Bronze Award for Executive of the Year – Small Companies.

  • Benzinga

    The US Cities Most Interested In Cannabis

    While cannabis has gone from a criminalized drug to a multibillion-dollar boom in recent years, very little data exists on how interest and consumer demand differ around the country, according to Michael Coleman, the vice president of sales and marketing at Medical Marijuana Inc (OTC: MJNA), told Benzinga. "We believe this study can be useful for cannabis executives and entrepreneurs who are looking to make strategic decisions about which markets to enter," he said of the company's most recent report on geographical interest on cannabis across the U.S. The following are highlights from Medical Marijuana Inc.'s report on interest in marijuana in cities nationwide.

  • PR Newswire

    Medical Marijuana, Inc. Reports $17.7 Million in Revenue in Q3 2019 Financial Results

    SAN DIEGO , Nov. 22, 2019 /PRNewswire/ -- Medical Marijuana, Inc. ("the Company") (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever ...

  • PR Newswire

    Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Vice President Invited to Speak on Key Panel at 2019 Marijuana Business Conference

    Caroline Heinz will speak on Dec. 12 at 2:00 p.m. on a panel entitled "Beyond Borders: Looking at Latin America as the New Frontier" discussing business opportunities allowed by regulations throughout Latin America, the current status of key revenue markets, challenges in each Latin American region and how they are being addressed, and Latin American cannabis investment opportunities. "Just like the U.S., Latin America is currently experiencing monumental shifts in acceptance and new legislation," Heinz said.

  • PR Newswire

    Medical Marijuana, Inc. Subsidiary Kannaway® Promotes Alex Grapov to Chief Sales Officer

    SAN DIEGO, Nov. 12, 2019 /PRNewswire/ -- Medical Marijuana, Inc. ("the Company") (MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® has promoted its International Vice President, Alex Grapov, to Chief Sales Officer of the Company. "Alex has been instrumental to our international sales and operational growth for the past two years and we believe that this new role is the most natural and well-deserved next step for him to take with our Company," said Kannaway® CEO Blake Schroeder.

  • PR Newswire

    Medical Marijuana, Inc. Subsidiary Kannaway® Receives Two 2019 BIG Awards for Business

    SAN DIEGO, Nov. 6, 2019 /PRNewswire/ -- Medical Marijuana, Inc. ("the Company") (MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® was named Small Business Company of the Year in the Life Sciences, Health, Wellness, and Nutrition category by the Business Intelligence Group's 2019 BIG Awards for Business. Also, Kannaway®'s CEO Blake Schroeder was named Small Business Executive of the Year in the Life Sciences, Health, Wellness, and Nutrition category.

  • PR Newswire

    Medical Marijuana, Inc. and Subsidiaries' 2019 Sales Bookings Surpass Total 2018 Sales Bookings

    SAN DIEGO , Nov. 5, 2019 /PRNewswire/ -- Medical Marijuana, Inc.  ("the Company") (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever ...

  • Medical Marijuana, Inc. Hires Tyler Whatcott as Chief Technology Officer
    PR Newswire

    Medical Marijuana, Inc. Hires Tyler Whatcott as Chief Technology Officer

    SAN DIEGO, Oct. 31, 2019 /PRNewswire/ -- Medical Marijuana, Inc. ("the Company") (MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that it has hired Tyler Whatcott as the Company's Chief Technology Officer. Mr. Whatcott will be responsible for developing and managing the company's information technology and web platforms as it develops its current business and expands around the world. "Tyler shows great promise in leading the technological operations of our Company as he has already proven his capabilities in leading several successful IT departments at well-established and recognized companies," said Medical Marijuana, Inc. CEO Dr. Stuart Titus.